Scan to Download Gate App
qrCode
More Download Options
Don't remind me again today

British officials announced Monday they've locked in a major win: zero tariffs on UK pharmaceutical exports to America for at least three years. The catch? London's committing to pump more cash into cutting-edge drug development. It's a strategic swap—market access in exchange for innovation investment. Worth watching how this reshapes transatlantic pharma flows and whether other sectors push for similar arrangements.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 6
  • Repost
  • Share
Comment
0/400
tx_or_didn't_happenvip
· 12h ago
Zero tariffs sound good, but the UK is being forced to spend money on R&D, it feels a bit like being trapped.
View OriginalReply0
0xSleepDeprivedvip
· 21h ago
Zero tariffs sound great, but can we really make sense of the costs involved in spending money on research and development?
View OriginalReply0
ReverseFOMOguyvip
· 21h ago
Ha, the UK is playing this "innovation for market" trick again... In plain terms, it's just about spending money to protect the market.
View OriginalReply0
ProposalManiacvip
· 22h ago
It's a typical market exchange investment game. Three years of zero tariffs look great, but that latter commitment is the real deal... For this type of arrangement to genuinely incentivize compatibility, it depends on how London chooses to spend the money on innovation, rather than turning it into a disguised subsidy.
View OriginalReply0
SignatureAnxietyvip
· 22h ago
Zero tariffs sound great, but it requires a lot of money for R&D. This time, the UK is really trapped, right?
View OriginalReply0
DefiEngineerJackvip
· 22h ago
well *actually* this is just regulatory theater masquerading as optimization... they're literally just paying for market access with taxpayer innovation funds, which is empirically a suboptimal capital allocation if you run the nash equilibrium analysis
Reply0
  • Pin
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)